Pfizer Laboratories

Pfizer is a leading global biopharmaceutical company dedicated to discovering, developing, and manufacturing innovative healthcare products. The company's extensive portfolio includes vaccines, oncology treatments, and medicines for immunology, cardiology, and rare diseases. Pfizer achieved worldwide recognition for the rapid development of the Comirnaty COVID-19 vaccine in collaboration with BioNTech and the antiviral treatment Paxlovid. With the 2023 acquisition of Seagen, Pfizer has significantly bolstered its leadership in oncology, particularly through advanced antibody-drug conjugate technologies. The company operates a vast global infrastructure, including state-of-the-art research centers and manufacturing facilities that supply medicines to over 125 countries. Pfizer continues to invest heavily in next-generation modalities such as gene therapy and mRNA to address significant unmet medical needs.